•
Dec 31, 2023

Lexicon Pharmaceuticals Q4 2023 Earnings Report

Total Revenue
$702K
Previous year: $28K
+2407.1%
EPS
-$0.2
Previous year: -$0.16
+25.0%
Research and development expenses
$14.8M
Previous year: $14M
+5.9%
Selling, general and admin expenses
$32.6M
Previous year: $16.3M
+99.6%
Gross Profit
$632K
Previous year: -$75K
-942.7%
Cash and Equivalents
$170M
Previous year: $138M
+22.9%
Free Cash Flow
-$50.5M
Previous year: -$22.8M
+121.6%
Total Assets
$229M
Previous year: $194M
+18.1%

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income